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Divergence in a master variator generates
distinct phenotypes and transcriptional
responses
Jennifer E.G. Gallagher,1,2 Wei Zheng,3 Xiaoqing Rong,2 Noraliz Miranda,4 Zhixiang Lin,5
Barbara Dunn,1 Hongyu Zhao,6,7,8 and Michael P. Snyder1,9
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06510, USA; 4University of Puerto Rico, Aguadilla, Puerto Rico 00604; 5Biological and Biomedical Sciences Graduate Program,
Yale University, New Haven, Connecticut 06520, USA; 6Program in Computational Biology and Bioinformatics, Yale University
School of Medicine, New Haven, Connecticut 06520, USA; 7Department of Epidemiology and Public Health, Yale University
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Genetic basis of phenotypic differences in individuals is an important area in biology and personalized medicine.
Analysis of divergent Saccharomyces cerevisiae strains grown under different conditions revealed extensive
variation in response to both drugs (e.g., 4-nitroquinoline 1-oxide [4NQO]) and different carbon sources.
Differences in 4NQO resistance were due to amino acid variation in the transcription factor Yrr1. Yrr1YJM789
conferred 4NQO resistance but caused slower growth on glycerol, and vice versa with Yrr1S96, indicating that
alleles of Yrr1 confer distinct phenotypes. The binding targets of Yrr1 alleles from diverse yeast strains varied
considerably among different strains grown under the same conditions as well as for the same strain under
different conditions, indicating that distinct molecular programs are conferred by the different Yrr1 alleles. Our
results demonstrate that genetic variations in one important control gene (YRR1), lead to distinct regulatory
programs and phenotypes in individuals. We term these polymorphic control genes ‘‘master variators.’’
[Keywords: 4NQO; S. cerevisiae; genetic variation; polymorphism; transcription factor]
Supplemental material is available for this article.
Received August 18, 2013; revised version accepted January 13, 2014.

How genetic variation produces different phenotypes and
the ability to adapt to distinct environmental challenges
is an important question in biology. Polymorphisms in
coding regions and regulatory elements have been shown
to associate with changes in individual morphological
phenotypes of multicellular organisms and survival characteristics in microorganisms (Rebeiz et al. 2009; Chan
et al. 2010; Gerke et al. 2010; Davidson 2011). However,
the extent to which variations in a single locus can generate
entirely distinct regulatory programs and phenotypes is
not well understood.
Alterations in gene regulatory components have been
shown to vary in a range of organisms and can lead to
distinct phenotypes. Loss of activity of transcription
factors (TFs) can lead to phenotypic differences; for
example, the loss of Pitx1 expression in stickleback fish
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leads to different body morphologies (Chan et al. 2010;
Infante et al. 2013), while variation in some TFs (e.g.,
Ime1, Rme1, and Rsf1) can alter sporulation efficiency in
different Saccharomyces cerevisiae strains (Gerke et al.
2009). Additionally, differences in gene expression and
TF-binding sites have been shown to vary considerably
between closely related species and individuals, although
how these differences affect phenotypes is often unknown (Borneman et al. 2006; Zheng et al. 2010). Although we know that phenotypic changes can result from
total loss of activity of TFs, it remains unclear whether
allelic variations in a single TF can mediate broad differences in molecular responses and complex phenotypes
through network rewiring. Such changes would be
expected to have important implications in the rapid
evolution of complex phenotypes and in allowing the
adaptation of organisms to new environments.

Ó 2014 Gallagher et al. This article, published in Genes & Development, is available under a Creative Commons License (AttributionNonCommercial 3.0 Unported), as described at http://creativecommons.
org/licenses/by-nc/3.0/.
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To better understand how phenotypes vary and evolve
among different individuals within a population or among
populations within a species, we analyzed different yeast
strains to find proteins that can regulate the phenotypic
response to the environment. Natural yeast strains are
more genetically diverse than humans (Wei et al. 2007)
and have been shown to vary considerably from laboratory strains in their response to different environmental
conditions such as growth on distinct carbon sources and
incubation in the presence of compounds and drugs (Liti
et al. 2009). The loci mediating some phenotypic differences among different yeasts have been mapped (Gerke
et al. 2009; Ehrenreich et al. 2010; Zheng et al. 2010),
although the number of genes that have actually been
identified is very limited.
We mapped the genetic basis of resistance/sensitivity
to 4-nitroquinoline 1-oxide (4NQO), a bulky alkylating
agent, in two yeast strains with very different responses
to this drug and identified a gene, YRR1, whose variation
strongly contributed to this phenotypic difference. Enhanced fitness in one condition resulted in diminished
fitness in another. When cells were able to grow well in
the presence of 4NQO, they then grew poorly in glycerol.
The phenotypic difference was largely associated with
changes in a single amino acid in Yrr1 that was a potential
site of phosphorylation. Importantly, Yrr1 bound different gene targets in different strain backgrounds, indicating that variation in a single TF can rewire transcriptional
networks. Thus, natural polymorphisms in a single regulatory gene can cause broad molecular changes that
result in distinct phenotypes in individuals, a phenomenon that has not been directly observed previously. To
distinguish this kind of protein sequence variation from
deleterious mutations, we term such genes whose natural
polymorphisms that cause broad molecular changes master variators.
Results
Different growth phenotypes among different
yeast strains
To explore the role of natural genetic variation in causing
phenotypic differences, we first analyzed the growth of
five haploid S. cerevisiae strains from diverse genetic and
ecological backgrounds under a variety of environmental
conditions. The strains examined were a common laboratory strain, S96 (derived from S288c background); two
clinical isolates, YJM789 and YJM339 (McCusker et al.
1994); and two vineyard isolates, AWRI1631 (Borneman
et al. 2008) and RM11 (Mortimer et al. 1994; Brem et al.
2002). The phenotypes analyzed included relative growth
in different carbon sources (glucose, ethanol, galactose,
and glycerol) and growth in the presence of different drugs
(4NQO, fluconazole, hydroxyurea, and nystatin) (Fig. 1A).
Fluconazole and nystatin both affect sterol metabolism,
and YJM789 sensitivity to these chemicals has been
recently linked to polymorphisms in the multidrug transporter Pdr5 (Guan et al. 2010). The genetic variation of
response to hydroxyurea remains unknown. The five strains
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Figure 1. Extensive variation in yeast growth under different
conditions and mapping of 4NQO response. (A) Tenfold serial
dilution of various strains of yeast spotted onto plates containing YPD, YPD + 0.2 mg/mL 4NQO, YP + 3% glycerol, YP + 2%
galactose, 2% ethanol, YPD + 5 mg/mL fluconazole, YPD + 200 mM
hydroxyurea, and YPD + 2 mg/mL nystatin and grown for 1–3 d at
28°C before being photographed. (B) Tenfold serial dilution of
S96, YJM789, and six segregants spotted onto plates containing
YPD and 0.2 mg/mL 4NQO and grown for 1–3 d at 28°C before
being photographed. (C) Genome-wide analysis study identified
a region on chromosome 15 with a LOD score of 25.50 for the
95% Bayes credible interval 639,300–640,218.

exhibited distinct growth characteristics under each of
the different conditions (Fig. 1A), and each strain had a
unique pattern of phenotypes. For example, relative to
other yeasts, RM11 grew well under fluconazole, and
YJM789 strains grew well in the presence of 4NQO; S96
cells grew slightly better on glycerol relative to YJM789
cells. Because the 4NQO resistance/sensitivity phenotype showed the most variation between the strains, we
chose to map the genetic basis of this phenotype using
the YJM789 and S96 strains, which exhibited the most
extreme phenotypes.
To map the loci responsible for the 4NQO response
variation, we used two previously sequenced yeast strains
(YJM789 and S96) and a large collection of 125 haploid
segregants that resulted from their cross (Wei et al. 2007;
Mancera et al. 2008); the genetic content of each of these
segregants was mapped at high resolution with highdensity microarrays. As shown in Figure 1B and Supplemental Figure S1, variation in the 4NQO response among
the different segregants was observed. The response of
segregants was scored and used as a quantitative trait for
linkage analysis between the individual trait and genetic
markers (see the Supplemental Material; Zheng et al.
2010). A strong peak associated with 4NQO response was
mapped to the right arm of chromosome 15 with a peak
logarithm (base 10) of odds (LOD) score of 25.5 (Fig. 1C).
Four other identified genomic locations, on chromosomes

Master variator regulates variation in phenotypes

1, 4, 5, and 7, had LOD scores outside the 95% confidence
interval (Supplemental Table 1) and thus were not investigated further.
Yrr1 mediates distinct responses to 4NQO
and growth on glycerol in different yeasts
Because of the large number of segregants analyzed, the
region associated with 4NQO response could be mapped
to a very narrow interval (Fig. 2A). Within this region was
YRR1, a gene encoding a TF. A strain containing a hypermorphic allele of YRR1 was previously found to be
resistant to 4NQO (Cui et al. 1998), but the variation of
YRR1 among different yeasts and its potential role in
conferring differential 4NQO resistance had not been
studied previously. To determine whether YRR1 was responsible for mediating variation in the 4NQO response,
we swapped the YRR1 alleles (termed YRR1YJM789 and
YRR1S96) between the two genetic backgrounds. YRR1S96
and YRR1YJM789 alleles on centromeric plasmids were
transformed into both wild-type and yrr1D mutant
strains. Importantly, when either the S96 wild-type strain
or its yrr1D derivative was expressing YRR1YJM789, it
showed a strong increase in 4NQO resistance compared
with S96 carrying an empty plasmid (Fig. 2B, rows 2, 7).
As expected, introduction of YRR1YJM789 into YJM789
yrr1D cells restored 4NQO resistance (Fig. 2B, rows 1,
4 vs. control S96 rows 2, 8; Supplemental Fig. S2). Wildtype YJM789 cells containing the YRR1YJM789 allele were
4NQO-resistant, also as expected. YJM789 yrr1D strains
containing the YRR1S96 allele as well as cells lacking any
plasmid had intermediate sensitivity to 4NQO, indicating that YRR1 is the major contributor to 4NQO resistance in this strain (Fig. 2A,B). We can also conclude
that the YRR1YJM789 allele is dominant over the YRR1S96
allele. The strong differences in growth observed on plates
were also evident using quantitative growth assays of cells
grown in liquid cultures containing 4NQO (Fig. 2C).
In our initial screens, we found that S96 cells grew
better on glycerol medium than YJM789 cells. We therefore examined whether YRR1 was involved in this phenotypic difference. Remarkably, we found that YJM789
strains (both wild type and yrr1D) exhibited a modest,
but reproducible, increased growth on plates containing
glycerol medium with expression of the YRR1S96 allele.
Interestingly, S96 cells containing the YRR1YJM789 allele
exhibited slightly slower growth on glycerol plates. The
results found on the plates were also reflected in the
quantitative cell culture assays (Fig. 2C); YJM789 cells
with the YRR1S96 allele grew 16% faster on glycerol
than wild-type YJM789 cells, while the S96 cells with
YRR1YJM789 had a 17% slower growth rate on glycerol
than wild-type S96 cells. Overall, these results indicate
that the YRR1YJM789 allele provided increased resistance
to 4NQO in the S96 background but reduced growth
on glycerol in either the YJM789 or S96 background. In
contrast, the YRR1S96 allele provided little to no resistance to 4NQO but led to increased growth on glycerol
in either strain background. These results indicate that
different YRR1 alleles confer distinct phenotypes and

Figure 2. Different alleles of YRR1 are responsible for 4NQO
resistance and rate of growth on glycerol. (A) Ninety-five
percent Bayes credible interval for the QTL region on chromosome 15 (coordinates 636,762–645,935) of the 4NQO data. The
LOD curve was calculated by standard interval mapping using
EM algorithm, and the Y-axis is 10^LOD rescaled to make the
area under the curve within 95% interval (shaded area) equal 1.
Associated marker names are also shown. Note that two markers
fall on the same map position, although their physical locations
are different (chromosome 15: 638,137–638,188, and chr15:
638,500–638,734). Genes are drawn to physical scale, and the
interval for each genetic marker is noted by lines between the
physical map in kilobases and map position in centimorgans.
Within this interval are the following genes: PNS1 (coordinates:
638,559–636,940) and YRR1 (coordinates: 641,993–639,561). (B)
Tenfold serial dilution of wild-type strains YJM789 and S96 and
yrr1D mutants carrying an empty plasmid (pGS35, a KANR
plasmid), pYRR1YJM789, or pYRR1S96 encoding the respective
alleles of YRR1 expressed from the endogenous promoters.
Strains were growth on YPD, YPD + 0.25 mg/mL 4NQO, and
glycerol with 200 mg/mL G418 and grown for 1–3 d at 28°C before
being photographed. (C) For cells grown in culture, the percentage
change in doubling time for YJM789 yrr1D and S96 yrr1D carrying
an empty plasmid or the exchanged allele as compared with
YJM789 yrr1D and S96 yrr1D carrying their respective alleles.

that the YRR1 variations that improve growth in the
presence of 4NQO cause reduced growth in glycerol.
Differences in coding sequences confer phenotypic
differences
Inspection of the predicted protein sequences of Yrr1
reveals that they contain multiple amino acid polymor-
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phisms among the YJM789, S96, AWRI1631, RM11, and
YJM339 strains. Four out of the five polymorphisms
within the coding region were nonconservative changes
and were located near the C terminus, and all were
outside the putative Zn finger DNA-binding, coiled-coil,
and activation domains (Fig. 3A). There were also four
polymorphisms seen in the promoter regions of YRR1YJM789
and YRR1S96. Two polymorphisms downstream from the
YRR1 gene are not transcribed (Xu et al. 2009) and were
not further studied. To determine whether the different

phenotypes among strains were due to differences in the
YRR1 promoter or in their coding sequences, several tests
were performed.
We first examined Yrr1 protein levels in all five backgrounds using immunoblot analyses (Fig. 3B; see also
the legend). Yrr1 was evident in all five strains (Fig. 3B),
although the levels varied modestly between strain and
condition. For cells grown on YPD and other conditions,
the levels of Yrr1 from all strains were compared with
Yrr1YJM789 grown in YPD. The level of Yrr1S96 protein
was 0.5 6 0.2-fold (YPD) or less (4NQO and glycerol) than
that of Yrr1YJM789 protein (average of three experiments)
(Fig. 3C). There was also a similar lower level of S96 YRR1
mRNA (0.60) compared with that of YJM789 using DNA
microarray analyses (data not shown). However, the level
of Yrr1 did not correlate to the rate of growth in any condition or strain. Therefore, to directly determine whether
differences in expression of YRR1 itself or coding polymorphisms alter the 4NQO response, we exchanged the
promoter regions of YRR1 from YJM789 and S96 backgrounds. The promoters from the two alleles of YRR1
were cloned in front of the other YRR1 allele on a plasmid
and expressed in both YJM789 yrr1D and S96 yrr1D. In
S96 cells, we detected only a very small increase of 4NQO
resistance when YRR1S96 expression was driven by the
YRR1 YJM789 promoter (Fig. 3D). Expression of the
YRR1YJM789 allele under the control of the YRR1S96 promoter conferred strong 4NQO resistance and was similar
to YRR1YJM789 under its endogenous promoter (Fig. 3D).
Protein levels were also assessed by immunoblotting of
Myc-tagged Yrr1 proteins immunoprecipitated from
yeast with both YRR1 alleles driven from each’s endogenous promoter or the promoter from the other allele.
There was only a slight increase of Yrr1S96 protein driven
from the YRR1YJM789 promoter and a slight decrease of
Yrr1YJM789 protein driven from the YRR1S96 promoter
(Fig. 3E). Therefore, although YRR1 expression levels may
contribute slightly to the different phenotypes, the polymorphisms in the coding region appear to be primarily
responsible for alterations in Yrr1.

Figure 3. Yrr1 contains polymorphisms in coding regions that
are responsible for most of the variation in 4NQO response. (A)
Sequence alignment of Yrr1 from five yeast strains. Polymorphisms are indicated with Zn finger, coiled-coil, and activation
domain boxed. (B) Immunoblot analysis of Yrr1-Myc immunoprecipitated from lysates from YJM789, S96, AWRI1631, RM11,
and YJM339 strains grown in YPD, 4NQO for 2.5 h, and glycerol
for 8.5 h. (C) The levels of Yrr1 immunoprecipitated via the
13xMyc tag from yeast were quantitated relative to Yrr1 from
YJM789 grown in YPD. An average of two to three experiments
is shown with standard deviations. (D) Tenfold serial dilution of
S96 yrr1D and YJM789 yrr1D carrying YRR1 with promoters
exchanged on plasmid pGS35; strains were incubated on YPD
and YPD + 0.25 mg/mL 4NQO plates for 1–2 d at 28°C before
being photographed. (E) Immunoblot of N-terminally Myc tagged
Yrr1 expressed from a plasmid with allelic promoter or transallelic promoter and immunoprecipitated from cells grown in
YPD. Cellular extract from cells carrying Yrr1YJM789-Myc tag was
incubated with protein A-conjugated agarose beads to control for
nonspecific interactions and run in lane 1, labeled Mock.

Specific variable amino acids in Yrr1 regulate
4NQO response
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Because all of the variation among the alleles of YRR1
was outside the DNA-binding domain, the variation in
Yrr1 function appeared to due to differences that lay in
other domains of the protein. Longer exposures of the
immunoblots revealed higher-molecular-weight proteins
that were detected with anti-Myc (Fig. 3E). Mock immunoprecipitations of Myc-tagged Yrr1 showed no nonspecific interactions (Fig. 3E, lane 1). To investigate the
nature of the slower-migrating bands of Yrr1, we treated
lysates with phosphatase (calf intestinal phosphatase
[CIP]) and immunoprecipitated Yrr1. The band with the
same migrating pattern as the predicted Yrr1-Myc protein
showed increased mobility, and some of the slower bands
also shifted down to the faster-migrating band. The fastestmigrating band of Yrr1 also showed a modest increase
when immunoprecipitated Yrr1YJM789 was treated with

Master variator regulates variation in phenotypes

CIP (Fig. 4A). At least one of the post-translational
modifications of Yrr1 was sensitive to dephosphorylation
treatment.
We compared the five coding polymorphisms between
Yrr1YJM789 and Yrr1S96 to examine whether any had an
effect on Yrr1 function, potentially through phosphorylation. T775 and S759 were the only two variable residues
that could be phosphorylated in Yrr1YJM789 and not in
Yrr1S96. To determine whether T775 has a role in Yrr1
4NQO resistance, we made site-directed mutations in
Yrr1YJM789 and Yrr1S96 (Fig. 4B). Serine and threonine are
amino acids with polar uncharged side chains. When
threonine and serine are phosphorylated, they become
strongly negatively charged. Mutating threonine and
serine to glutamate mimics that strong negative charge
of phosphorylation. Mutating these residues to an alanine, a nonpolar amino acid, would prevent a negative
charge. We tested the effect of site-directed mutation by
mutating variable residues on plasmid-encoded Yrr1 to
glutamate (E) or alanine (A) and testing the growth of
transformed S96 yrr1D. Mutation of amino acid T775 to
E in both the Yrr1YJM789 and Yrr1S96 alleles increased
4NQO resistance to even greater than the wild-type
Yrr1YJM789 (Fig. 4B). Expression of the yrr1YJM789 T775E
allele conferred greater 4NQO resistance than yrr1YJM789
T775A or Yrr1YJM789. Therefore, yrr1YJM789 T775E and
yrr1S96 T775E were hypomorphic alleles. yrr1YJM789
T775A and yrr1S96 I775A did not change 4NQO resistance compared with the respective wild-type Yrr1 alleles. The yrr1YJM789 S759E mutation did not significantly change the 4NQO resistance of the strain, while
the yrr1YJM789 S759A resulted in greater 4NQO sensitiv-

ity. Mutating 775 to a negatively charged amino acid
conferred greater 4NQO resistance than the resistant
Yrr1YJM789 allele alone. We postulate that while T775
could be the major residue of interaction, the increased
sensitivity of yeast expressing yrr1YJM789 S759A suggests
that both residues are sites of regulation. We made
a double mutant (yrr1YJM789 S759A T775A), expressed it
in S96 yrr1D yeast, and found that the yeast were more
sensitive than with Yrr1YJM789 bearing either single mutation but not as sensitive as Yrr1S96-expressing yeast (Fig. 4C).
We examined two variable residues of Yrr1 that are
potential phosphorylation sites and mutated them to
glutamate to change the charge. Only one other site in
Yrr1 varies in a way that changes the charge of the protein. Amino acid 673 is a glutamate in Yrr1YJM789 and
a glycine in Yrr1S96, giving rise to different charges at this
site. To investigate the impact of amino acid 673 between
the different alleles of Yrr1, we mutated that site and
tested the 4NQO resistance. S96 yrr1D yeast expressing
yrr1YJM789 E673G were as 4NQO-sensitive as yeast
expressing Yrr1S96 (Fig. 4B). However, the converse was
not true: Yeast expressing yrr1S96 G673E were as 4NQOsensitive as Yrr1S96-expressing yeast. We further investigated these mutants by introducing mutations at 775
(Fig. 4D). Both the yrr1YJM789 T775E and yrr1S96 I775E
alleles conferred strong 4NQO resistance to yeast.
yrr1YJM789 E673G converted this allele from YJM789 to
a 4QNO-sensitive one, and combining this mutation
with T775E restored 4NQO resistance. The double mutants of both alleles (yrr1YJM789 E673G T775E and yrrS96
G673E I775E) were converted to 4NQO-resistant alleles.
Consistent with multiple post-translational modifica-

Figure 4. Variation in a single amino acid of Yrr1YJM789 contributed to 4NQO resistance. (A) Immunoprecipitation of pMyc-Yrr1YJM789
from S96 lysate treated overnight with CIP. (B) Tenfold serial dilution of S96 yrr1D carrying either plasmid with the indicated single
amino acid mutant alleles of Yrr1YJM789 or Yrr1S96 on YPD and YPD + 0.3 mg/mL 4NQO plates for 2 d at 28°C before being
photographed. The mutations 775E, 775A, 756E, and 756A were generated in both alleles of Yrr1. The amino acid at position 673 was
polymorphic between the two alleles and was switched in Yrr1 alleles to generate yrr1YJM798 E673G and yrr1S96 G673E alleles. S96
yrr1D with an empty plasmid is noted with a dash at the top of each plate. (C) A double mutant of yrr1YJM789 S796A and T775A was also
transformed into S96 yrr1D yeast, and the resistance to 0.3 mg/mL 4NQO was tested. (D) Double amino acid substitutions at positions
673 and 775 as indicated were generated for each Yrr1 allele, and the growth on 0.25 mg/mL 4NQO was tested.
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tions of Yrr1, there were multiple variable amino acids
that regulate Yrr1’s response to 4NQO.
Assessing the effect of yrr1S96 I775E
on the genomic localization
Mutation of the variable amino acid 775 to a glutamate
increased the 4NQO resistance above the 4NQO resistance allele Yrr1YJM789. This mutation is in the C-terminal region of the protein and is not predicted to affect the
Zn finger-binding domain (Fig. 3A). To test whether the
yrr1S96 I775E allele would change the genomic location of
the TF, we mapped the chromatin-binding sites for the
different Yrr1 alleles using chromatin immunoprecipitation (ChIP) followed by Illumina sequencing (ChIP-seq),
and the reads were mapped back to the reference genome
using CisGenome (Supplemental Table 2; Johnson et al.
2007; Robertson et al. 2007; Ji et al. 2008). N-terminal
13xMyc-tagged Yrr1 alleles were expressed from plasmids that were transformed into S96 yrr1D; this design
avoided complications due to differences in genetic
backgrounds and also ensured that the only Yrr1 allele
expressed was the one present on the plasmid. S96 yrr1D
strains carrying either Yrr1YJM789, Yrr1S96, or yrr1S96
I775E were grown in YPD only or in YPD and then shifted
to 4NQO for 2.5 h. Sequenced reads were obtained from
three independent biological replicate experiments, along
with ‘‘input’’ controls (which gave little background, as
described previously; Lefrancois et al. 2009). Across the
three strains and two conditions, a total of 329 peaks were
identified using CisGenome (Ji et al. 2008) as potential

binding sites of Yrr1 (Supplemental Table 3). Cluster
analysis was performed on the ChIP-seq peaks to assess
any similarities in patterns of TF-binding. The yrr1S96
I775E peaks from YPD-and-4NQO-treated cells clustered
with Yrr1YJM789 peaks from 4NQO-treated cells but not
with Yrr1S96 peaks from YPD- or 4NQO-grown cells
(Fig. 5A). While these patterns of Yrr1 binding were the
most similar, there were additional loci bound by Yrr1S96
I775E in 4NQO-treated cells not seen in Yrr1S96 I775E
from YPD-grown cells. There is a group of loci bound by
Yrr1YJM789, but there was little to no binding by Yrr1S96
I775E when cells were grown in YPD or 4NQO. This
suggests that although amino acid 775 played the major
role in regulating 4NQO responses, some other variable
amino acids also contributed to the binding variation of
Yrr1 in response to 4NQO.
To assess the impact of Yrr1S96 on individual loci, three
loci were closely examined for each condition and allele.
We saw that the mutation I775E converted Yrr1S96 to
mimicking the behavior of Yrr1YJM789 allele in cells grown
in 4NQO (Fig. 5B; Supplemental Table 4). Yrr1YJM789 from
cells grown in 4NQO (but not in YPD alone) as well as
Yrr1S96 I775E from cells grown in either 4NQO or YPD
alone bound upstream of YAR068w. The peaks of
Yrr1YJM789 and Yrr1S96 I775E grown in 4NQO were similar, while the peak from Yrr1S96 I775E grown in YPD was
narrower. Expression of YAR068w is induced in petite cells
(respiration-deficient yeast) (Epstein et al. 2001). The peak
over coding region of FMP52, a gene encoding a mitochondrial protein that is induced in DNA damage (Dardalhon
et al. 2007), also shifted between alleles and conditions.

Figure 5. Genomic locations of yrr1S96 I775 compared with Yrr1S96 and Yrr1YJM789 grown in 4NQO. Yrr1 targets were mapped in the
S96 yrr1D indicated yeast strains using ChIP-seq. (A) Heat map of overlapping peak regions across different alleles and conditions. Log2
fold changes [log2(FCs)] between normalized ChIP and control reads for each overlapping peak region were determined and compared
across different yeast strains. A list of the overlapping peak regions and their log2(FC) values are provided in Supplemental Table 4. (B)
Yrr1 ChIP-seq signal tracks from three regions of the genome, including SNQ2 and YAR068w and between FMP52 and PMI40. The
Y-axis is log2(FC), and the X-axis is the chromosome location with the chromosome and coordinates of each region noted.
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Yrr1YJM789 in 4NQO, yrr1S96 I775E in YPD, and yrr1S96
I775E in 4NQO did bind known transcriptional targets; for
example, the promoter of SNQ2. Snq2 is an ABC plasma
membrane transporter that is required for resistance to
many chemicals, including 4NQO (Servos et al. 1993) and
reactive oxygen species (ROS) (Ververidis et al. 2001), and
is known to be regulated by Yrr1 (Le Crom et al. 2002).
For many loci, mutation of isoleucine 775 to glutamate in
the S96 allele of Yrr1 mimicked 4NQO treatment of
Yrr1YJM789.
Mapping Yrr1-binding regions across genetically
diverged yeast strains
The differences in phenotypes conferred by the YRR1
alleles from the two strain backgrounds could be due to
a number of possibilities. To determine how much the
binding of Yrr1 could change in both 4NQO and glycerol,
we therefore mapped the binding sites of Yrr1 in the five
different strain backgrounds. Yrr1 from AWRI1631,
RM11, and YJM339 contains other sequence differences
compared with S96 and YJM789 that alter binding to
distinct gene targets. For each strain, targets were mapped
in cells grown under three different conditions: rich
medium (YPD), 4NQO, and glycerol. The sequencing
reads were generated and mapped directly to their respective yeast genomes to avoid mapping biases (see the
Materials and Methods; Supplemental Table 5). Significant Yrr1 peaks were scored with CisGenome (Ji et al.
2008) using a variety of parameters (Supplemental Table
6). For the results described below, we used a reasonably
stringent threshold that provided a low false discovery
rate (FDR; 1%); qualitatively similar results were observed
using a range of different thresholds (see the Supplemental
Material for further discussion).
Overall, we identified 125–411 binding regions in the
different yeast strains and conditions (Table 1); in general,
Table 1.

the highest number of total peaks was identified in cells
grown in YPD (n = 411–256), and fewer were found in cells
grown in the presence of 4NQO (n = 376–125) or glycerol
(n = 387–130). Analysis of all of the genes associated
with Yrr1-bound regions from all ChIP-seq experiments
showed enrichment for genes involved in drug response
even when cells were grown in the absence of drugs in
rich medium or glycerol (Supplemental Tables 7, 8).
Yrr1 has different gene targets in different yeast
backgrounds and conditions
Analysis of Yrr1-binding regions revealed that there are
extensive differences in both the different yeasts grown
under the same condition and the same yeast grown
under different conditions. To some extent, most peak
regions bound by Yrr1 changed between either strains or
conditions. Examples of these variations are shown in
Figure 6A.
The peak region in the intergenic space between YNG1
and CYT1, which encode a subunit of the NuA3 histone
acetyltransferase and cytochrome c1, respectively, decreased in AWRI1631, RM11, and YJM339 in 4NQO
and glycerol media relative to S96 and YJM789. Cyt1
localizes to the mitochondria and has a role in heme
biosynthesis. Varied binding patterns upstream of either
gene could be partially responsible for the observed
phenotype. An example is the Yrr1 peak upstream of
SNQ2, which is one of the strongest peaks in most strains
and did not vary between different alleles of Yrr1 seen in
Figure 5B. The peak was strongest in AWRI1631 grown in
YPD and YJM789 grown in glycerol, while peaks in other
strains and conditions were about half as strong. The
pattern of peaks upstream of GIS1 was similar across all
conditions in AWRI1631, RM11, and YJM339 but varied
greatly between S96 and YJM789. Gis1 is a Zn finger TF
with a jumonji demethylase domain regulating phospho-

Yrr1 ChIP target and overlaps between strains

Medium

Strain

Peaks

YJM789

S96

AWRI1631

RM11

YJM339

YPD
YPD
YPD
YPD
YPD
4NQO
4NQO
4NQO
4NQO
4NQO
Glycerol
Glycerol
Glycerol
Glycerol
Glycerol

YJM789
S96
AWRI1631
RM11
YJM339
YJM789
S96
AWRI1631
RM11
YJM339
YJM789
S96
AWRI1631
RM11
YJM339

277
411
262
387
259
148
125
138
131
376
130
144
138
131
387

1
21
11
31
7
0
34
42
8
49
59
39
42
47
49

6
2
17
9
17
33
10
33
40
64
60
2
0
10
64

14
39
3
28
3
18
51
0
5
0
89
79
0
29
0

5
7
11
3
11
9
44
0
11
0
61
18
0
0
0

9
9
11
31
12
7
23
4
1
4
61
14
0
2
4

Number and percentage of unique peaks for each pairwise strain/condition combination. Off-diagonal entries are the number of peaks
substantially different (log2 normalized signal threshold) in the two-way comparison; e.g. in the cell at the intersection of row S96 (411)
and column YJM339, 9% of the 411 binding regions in S96 are different in the two-way comparison of S96 and YJM339 under YPD
growth condition. Along diagonal entries are the number of unique binding regions (shaded) in one strain but different from the other
four strains under each condition; e.g. at the intersection of row S96 (411) and column S96, 2% of the 411 binding regions in S96 are
different from other binding regions in the other four strains under YPD growth condition.
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Figure 6. Differential binding at distinct targets from
five different strains in three different growth conditions. (A) Yrr1 ChIP-seq signal tracks from YJM789
(blue), S96 (red), AWRI1631 (green), RM11 (purple), and
YJM339 (orange) were drawn for peak regions in YPD,
4NQO, and glycerol media with the input tracks below
each ChIP track. Genes with 59 ends downstream from
peak regions ae indicated above the signal tracks, and
corresponding regions on chromosomes are shown
below. The black line represented the chromosome,
and the scale is noted by a bar demonstrating 1 kb (Xaxis). ORFs are boxed in black. The scale for each signal
track for a condition was drawn to fit and is noted
above the signal tracks (Y-axis). (B) Yrr1 ChIP-seq signal
tracks from YJM789 (blue) and S96 (red) from the three
different conditions were drawn in the same scale for
each peak region (Y-axis). The same schematic was used
as described above to represent genes. Note that differential Yrr1 binding was observed for the different
yeasts; in some cases, binding is similar under one
condition but different in another (e.g., QCR2 in YPD
compared with glycerol); in other cases, binding is
different in all conditions (e.g., FLR1).

lipids levels (Oshiro et al. 2003), transcription of starvation genes, and DNA damage response (Jang et al. 1999).
The GIS1 peak was similar across different strains in YPD
but increased in YJM789 grown in glycerol and also in S96
grown in 4NQO compared with other strains grown in
the same conditions. The binding pattern between IPT1
and SNF11 was similar to that observed for GIS1. Snf11
is a component of the Swi/Snf chromatin remodeling
complex (Treich et al. 1995) and Ipt1, an inositolphosphotransferase that has a role in drug resistance (Hallstrom
and Moye-Rowley 2000). The binding pattern of the Yrr1
upstream two genes encoding ribosomal proteins also
was similar to the strongest binding observed in YJM339
grown in 4NQO. Overall, the most variation in the number
of peaks among the different yeast was observed in 4NQO
(STD = 107.9) and glycerol (STD = 112.5) as compared with
YPD (STD = 73.6).
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It is possible that the variation in Yrr1 binding across
all strains was due to an overall reduced level of Yrr1’s
ability to bind DNA in different strains. However, we do
not believe that this is the case because we observed some
peaks with similar levels among the different strains (e.g.,
the intergenic peak between YNG1 and CYT1 varied less
than twofold for strains grown in YPD) and because we
observed some very strong peaks in any given strain
and condition (e.g., between IME1 and RPL43b). We also
performed a systematic analysis, as described in the next
section.
Varied patterns of binding across different strains
and conditions revealed by systematic analysis
To compare all peaks among the different strains, we used
the stringent criteria described in the Materials and

Master variator regulates variation in phenotypes

Methods and a pipeline similar to that described previously (Kasowski et al. 2010; Zheng et al. 2010). We first
identified the regions that bound Yrr1 in the different
strains and determined the normalized signals in these
regions for each of these strains. We then analyzed the
differences in signals as well as the percentage overlap of
the binding regions. We first determined the correlation
of signals in all Yrr1-bound regions between (1) the same
strain grown in different conditions (Supplemental Fig. 8),
(2) different strains in the same condition, and (3) as a
control, the independent biological replicates from the
same strain. The individual comparisons are presented
in Supplemental Figures S4 and S5, and the results are
summarized in Figure 7A. For the Yrr1-bound regions, the
correlations in normalized signals between different
strains and different conditions were significantly lower
than the correlations between biological replicates (Wilcoxon
rank-sum test, P = 0.02635 and P = 0.02042, respectively)
(Fig. 6A), indicating significant variation in binding among
the different strains grown in the same condition and the
same strain grown under different conditions. Overall,
there was just as much variation in Yrr1 targets between
strains as there was between different conditions.
For each binding target location, we also examined
the differences in normalized binding signals for all five
strains and all three conditions using the clustering
diagram depicted in Figure 6B. As is evident in the figure,
extensive Yrr1 target and signal differences exist between
each of the different strains irrespective of the growth
conditions. However, some strains do appear more similar to one another under the same conditions (e.g.,
AWRI1631 and RM11 in 4NQO and RM11 and S96 in
glycerol) (Supplemental Fig. S5). Interestingly, in at least
two cases, the patterns appeared similar for different
yeast exposed to different conditions (e.g., YJM789 and
S96 grown in glycerol and 4NQO, respectively). These
results are also evident from the pairwise correlation
analyses (Supplemental Fig. S6) and suggest that the yeast
TFs can switch their binding programs.
We also determined the number of binding sites that
were unique or substantially different in signal (more
than twofold apart in normalized signal) between the
different yeast strains grown under both the same and
different conditions. Consistent with the heat map results (Table 1), we observed extensive divergence in
similar binding sites among the different yeast grown in
the same condition as well as for the same yeast grown
in different conditions. For example, YJM789 and S96 had
33% and 40% unique/different binding sites (more than
twofold) for cells grown on glycerol or in the presence of
4NQO, respectively. To ensure that these differences
were not due to threshold effects, two analyses were
performed. First, we changed the threshold of fold differences and found similar results (data not shown). Second,
we examined the signals of peaks that were not found to
be overlapping; potentially, many of these might lie just
below the threshold. As shown in Supplemental Figure
S7, although some peaks may be similar and fall below
the threshold in one of the strains, a large number of
peaks were very different, and the Yrr1 ChIP signal was

Figure 7. Different binding targets of Yrr1 among five yeast
strains. Yrr1 targets were mapped in five indicated yeast strains
using ChIP-seq. (A) A summary of the pairwise correlations
between peak signals (log read counts) in ChIP samples of two
biological replicates of the same strain (left), the same strain
under different conditions (middle), and different strains under
the same condition (right). Correlations between different
strains grown under the same conditions or the same strains
grown under different conditions were significantly different
from that observed for biological replicates (significance differences between replicates and conditions [Wilcoxon rank-sum
test, P = 0.026] or different strains [Wilcoxon rank-sum test, P =
0.020]), whereas correlations between conditions and between
strains were not significantly different (Wilcoxon rank-sum test,
P = 0.4526). (B) Heat map of overlapping peak regions across
different strains and conditions. Log2 fold changes between
normalized ChIP and control reads for each overlapping peak
region were determined and compared across different yeast.
A list of the overlapping peak regions and their log2(FC) values
is provided in Supplemental Table 7.

near background levels in one strain or the other. Overall,
these results indicate that both the number of Yrr1
targets and their binding signals often vary among different yeasts.
Extensive variations in Yrr1 localization were evident
at different loci in the different yeast and conditions.
Common overall patterns were evident based on the
dendrogram above the heat map (Fig. 7B). In general,
Yrr1 from cells grown in glycerol had more similar
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patterns of binding than that from cells grown in YPD or
4NQO. The two Yrr1-binding patterns that were the
most similar were in S96 grown in 4NQO and in
YJM789 grown in glycerol. PDR3, SNQ2, PDR15,
YOR1, PDR16, and PDR5, which were strongly associated with Yrr1 in all strains and conditions, were involved
in drug response including Yrr1 itself (Supplemental
Table 8).
From the peaks identified from the ChIP-seq analysis,
we also performed a de novo motif search for Yrr1binding sites (see the Materials and Methods) in all strains
and growth conditions using MEME and recovered the
consensus binding sites (Supplemental Fig. S8). These
searches revealed distinct but related consensus binding
sites among one another, which were also related to
the published consensus (RCGGRDWTWD) (Zhu et al.
2009). In particular, the consensus binding site from S96
in 4NQO was very similar to the binding sites seen in
S96, RM11, and YJM339 grown in glycerol. AWRI1631
binding sites from glycerol showed some similarity to
YJM789 grown in YPD. In many cases, when there was
a similar deduced motif, there was also a similar Yrr1binding pattern (e.g., AWRI1631 in 4NQO and glycerol
media). However, overall, we did observe condition- and
strain-specific variations, suggesting that the binding preference may differ across different growth conditions.

Discussion
We identified and characterized a single protein (Yrr1)
that affected growth in three different conditions and is
polymorphic across diverse yeast strains. The polymorphisms in YRR1 were outside the DNA-binding region,
with the nonconservative substitutions located at the C
terminus. One of the residues, at position 775, was likely
the major reason for these different phenotypes, as
changing it to a glutamate causes 4NQO resistance in
an otherwise sensitive strain. Since conversion to an
alanine does not eliminate 4NQO resistance in YJM789,
we propose that other residues are responsible for the
phenotypic variations as well. Without glutamate at 673,
the Yrr1YJM789 could not confer 4NQO resistance without
mutation of 775 to a glutamate. Unlike the I775E substitution in Yrr1S96, mutation of 673 to a glutamate could
not convert the Yrr1S96 allele to a 4NQO-resistant allele.
We further propose that these Yrr1 amino acid differences
lead to variations in association with protein partners/
cofactors such as kinases, which in turn results in
selection of different binding targets. Since previous
studies have shown in yeast and humans cells that TFs
often have different partners at distinct loci that are
important for binding (Kasowski et al. 2010; Zheng
et al. 2010; Karczewski et al. 2011), it is likely that
Yrr1 has distinct partners at different targets, varying in
the different strains and under the different conditions. A
likely candidate is a serine/threonine kinase that phosphorylates polymorphic sites in Yrr1 in response to
4NQO. The interaction of regulatory enzymes and their
substrates is difficult to characterize and often requires
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overexpression or in vitro purification to monitor physical interactions (Ruiz et al. 2011). It is interesting that
Yrr1 targets are sometimes more similar in different
strains grown under different conditions then in either
the same strain grown under different conditions or different strains grown in the same conditions. The simplest
explanation for this observation is that different factors
work with Yrr1 under different strains and conditions and
that some of these combinations are shared in those
cases. It is likely the amino acid variations that are responsible for these interaction differences, which is
consistent with our demonstrating that coding sequence
changes are primarily responsible for the phenotypic
differences that we observed.
Yrr1 is polymorphic among different yeast strains, and
we propose that this TF belongs to a class of regulatory
proteins that we call ‘‘master variators.’’ We suggest that
master variators are proteins that have three characteristics: (1) They are polymorphic; (2) they are regulatory
proteins such as TFs, proteins kinases, and other modification enzymes; and (3) they affect significant numbers of
downstream targets. In contrast to deletions, study of
natural variation would likely limit suppressor mutations
that would compensate for severe phenotypes (Teng et al.
2013). Variation in Yrr1 and other master regulators can
cause significant differences in phenotypes through alteration in regulatory programs rather than simply loss or
reduction of function, as has been described previously
(Chan et al. 2010). These alterations can improve one
phenotype at a cost to another; indeed, the Yrr1YJM789
allele improves growth in the presence of 4NQO but
reduces growth in glycerol even when the allele responsible for improved growth on glycerol is present. Variation of Yrr1 between EC1118 and S288c affects the
regulation of SNG1 during the fermentation process
(Brion et al. 2013). We note that this concept is different
from that reported by others in which loss of function
causes a distinct phenotype. For Yrr1, we observed a
phenotype transformation due to a single gene through
molecular reprogramming.
The mechanism by which Yrr1 causes distinct phenotypes is not known in detail but may involve differences
in many different binding targets. Yrr1 binds upstream of
many genes affecting mitochondrial function and drug
response, and these targets differ in the different strain
backgrounds (Supplemental Table 9). For example, Yrr1 is
differentially bound upstream of ISU1, QCR2, and TBS1
(genes involved in mitochondrial function in S96 and
YJM789) in some conditions, and in other conditions, it
binds upstream of PDR5, SNG1, and FLR1 (genes involved in drug response) (Fig. 6B). Yrr1 activity correlates
with SNG1 and FLR1 expression (Le Crom et al. 2002;
Teixeira et al. 2008; Brion et al. 2013; Kodo et al. 2013),
and thus Yrr1 is likely a direct activator of gene expression of these targets. Yrr1 binding in YJM789 at these and
other regions may facilitate 4NQO resistance. Interestingly, Yrr1 is thought to be a repressor as well as an
activator because its activity can affect genes in different
ways (Cui et al. 1998; Zhang et al. 2001; Le Crom et al.
2002; Lucau-Danila et al. 2003). Thus, its variation in
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binding at different gene targets can alter expression in
different ways; as such, its control over variation as
a master variator likely affects gene expression in very
different ways and thus leads to the great extent of phenotypic diversity.
In conclusion, we demonstrate that variation in an
important TF is responsible for major phenotypic changes
in yeast. Previous studies have highlighted the elevated
levels of nonsynonymous changes in TFs among different
yeast strains (Gu et al. 2005). Since many human TFs and
other regulatory proteins are also polymorphic, it is likely
that some of these potential master variators may also be
responsible for phenotypic differences, and thus this may
be a general mechanism for mediating extensive regulatory (e.g., expression and binding QTLs) and phenotypic
variation in all eukaryotes.
Materials and methods
Yeast strains and plasmids

washed with YP and shifted to YP + glycerol for 8.5 h. Cells were
lysed in the Fastprep for 20 sec at speed 5 and then ice for 5 min
three times in 50 mM Tris HCl (pH 7.8), 150 mM NaCl, 4%
glycerol, 1.5 mM Mg acetate, and 0.15% NP-40. Clarified extract
(1.5 mg) was incubated with 35 mL of 50% anti-Myc EZ-view
affinity gel (Sigma-Aldrich) for 2 h to overnight at 4°C. Washed
immunoprecipitates were boiled with Lammeli sample buffer,
separated on 4%–12% polyacrylamide gel, and transferred to
nitrocellulose. Westerns were blotted with mouse anti-Myc
9E10 (Sigma). To determine whether there was any background
in the immunoprecipitations, a mock immunoprecipitation was
carried out with Yrr1-Myc-tagged lysate and protein A-agarose
beads. Lysate was treated with 15 mL of CIP overnight at 4°C, and
then Yrr1-Myc was immunoprecipitated.
4NQO response QTL mapping
A total of 124 S96/YJM789 segregants (Mancera et al. 2008) was
manually scored for growth on 4NQO medium on a scale of 0–5.
Their specific genotypes at 55958 SNP marker loci were filtered
(must have more than four strains of either parental genotype)
and reduced to 5523 nonredundant genotype blocks. Onedimensional QTL scanning was performed using the R package
qtl with EM method. The 95% Bayes credible interval was
calculated for the highest peak on chromosome 15. The significance threshold was above LOD 3.84 after 1000 permutations,
and the peak above YRR1 was the only QTL that passed the
threshold. The peak was represented by 10^LOD rescaled to make
the area under the curve equal 1.

All yeast strains used in this study are haploids and are described
in Supplemental Table 10. S96 (isogenic to S288c) is a laboratory
strain, YJM789 was derived from a clinical isolate from the
lungs of an AIDS patient (McCusker et al. 1994; Wei et al. 2007),
AWRI1631 was derived from a wine strain (Borneman et al.
2008), and RM11-1b was derived from the vineyard diploid by
removing HO and was sporulated, and the KANR was removed as
described (Gueldener et al. 2002). YJM339-2d was derived from
a clinical isolate from a human bile tube (McCusker et al. 1994),
and a stable haploid was generated as RM11-1b. pGS35 (KANR)
and pGS36 (HYGR) are centromeric plasmids that were a gift
from Gavin Sherlock. All oligonucleotides used are described in
Supplemental Table 11. YRR1 with the endogenous promoter
and terminator were cloned by homologous recombination into
the XbaI and SpeI sites into pGS35. The entire transcriptional
unit of YRR1 was selected, and the promoter contained four
polymorphs, while downstream polymorphisms occured downstream from the transcriptional stop of the YRR1 mRNA (Xu
et al. 2009). Yeast were grown under standard conditions and
transformed as outlined in Gietz and Schiestl (2007). YRR1 was
tagged both at the C terminus with the 13xMyc tag marked with
KANR (Longtine et al. 1998) and at the N terminus by PCRstitching the 13xMyc tag to the coding region of YRR1YJM789 and
YRR1S96 and cloning into pSG35. Endogenous YRR1 was deleted
via homologous recombination with HYGR (Goldstein and
McCusker 1999), and plasmids were transformed into strains
using standard lithium acetate transformation. Plasmids were
maintained by addition of 200 mg/mL G418 for selection. Sitedirected mutagenic PCR was carried out with overlapping primers
containing each of the mutations and flanking primers used for
cloning. The 59 and 39 PCR products were then used as templates
to PCR-stitch yrr1 with the mutation. yrr1 alleles were cloned into
pGS35, and mutations were verified by sequencing the plasmid.
Growth rates were calculated by measuring the OD600 of a yeast
culture grown to log phase in YPD, washed, and suspended in
30 mL of 4NQO or YPglycerol. Readings while the culture was in
exponential growth were fitted to a log scale. The doubling time
in hours was derived by the equation fitted to the growth curve.

Cells were grown in YPD to mid-log phase, diluted to early log
phase, and split into three cultures. YPD cultures were grown for
2.5 h. 4NQO (0.25 mg/mL) dissolved in DMSO (Sigma) was added
for 2.5 h. The third culture was washed with YP and shifted to YP
+ glycerol for 8.5 h. Thirty-five OD units were cross-linked with
1% formaldehyde for 45 min before being washed once with
water and flash-frozen. ChIP was carried out as described
(Lefrancois et al. 2009) with the following modifications: The
addition of glycine was omitted, and 35 mL of 50% anti-Myc EZview affinity gel was added (Sigma-Aldrich). Two-hundred nanograms of chromatin was used as input controls. The construction
of multiplexed barcoded libraries permitted the simultaneous
sequencing of 24 samples in the Illumina HiSeq sequencers
(Lefrancois et al. 2009). Libraries were sequenced on Illumina
HiSeq as 100-base-pair (bp) paired-end reads. For different allelic
ChIP of pMyc-Yrr1, there were three biological replicates for
ChIP of each treatment and one replicate for input. The average
generated reads were 3,357,478, and the alignment rate was
99.17% for ChIP samples; the average generated reads were
3,134,818, and the alignment rate was 98.70% for input. ChIP
from different strains with Yrr1-Myc tag was carried out as
described (Aparicio et al. 1991). Two to three biological replicates
of genetically divergent strain ChIP samples were sequenced on
Illumina GAII as 32-bp single-end reads, generating an average of
2.66 million post-filtered reads, with 64% mapping back to the
genome; the input samples generated an average of 3.55 million
post-filtered reads, with 77% mapping back to the genome. Normalized peak signals on log2 scale for all strains and conditions were
clustered by Euclidian distance using heatmap.2 function in R.

Immunoprecipitation
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